Heron Therapeutics, Inc.
HRTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000818033
No open-market purchases or sales by Heron Therapeutics, Inc. insiders were filed in the last 90 days; 163 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Heron Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 186 | 3 | 174 | −9 |
| Shares | 108.5M | 242.7K | 115.3M | +6.96M (+6.4%) |
| Value | $620.5M | $1.39M | $321.6M | −$297.6M (−48.1%) |
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Heron Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Oconnor LLC | 10,145,000 | $28.3M | 0.30% |
| Balyasny Asset Management LLC | 503,685 | $1.41M | 0.01% |
| Twinbeech Capital LP | 398,673 | $1.11M | 0.05% |
| Gagnon Securities LLC | 367,514 | $1.02M | 0.21% |
| Jane Street Group, LLC | 130,284 | $363.0K | 0.00% |
| Two Sigma Investments, LP | 107,055 | $299.0K | 0.00% |
| SG Americas Securities, LLC | 93,266 | $260.0K | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 27,245 | $76.0K | 0.00% |
| Simplex Trading, LLC | 18,901 | $52.0K | 0.00% |
| Ingalls & Snyder LLC | 14,115 | $39.0K | 0.00% |
| Two Sigma Securities, LLC | 10,685 | $30.0K | 0.01% |
| Aquatic Capital Management LLC | 9,500 | $27.0K | 0.01% |
| Eagle Bay Advisors LLC | 193 | $538 | 0.00% |
| Howe & Rusling Inc | 50 | $0 | 0.00% |
| Glassman Wealth Services | 35 | $0 | 0.00% |
| Lindbrook Capital, LLC | 73 | $0 | 0.00% |
| CoreCap Advisors, LLC | 117 | $0 | 0.00% |
Sold out (26)
Institutions that held Heron Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (3)
Institutions that held Heron Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 216,477 | $1.24M |
| Amalgamated Financial Corp. | 15,043 | $86.0K |
| Virginia Retirement Systems Et Al | 11,200 | $64.0K |